Kazia Therapeutics (KZIA) Other Non-Current Assets (2018 - 2025)
Kazia Therapeutics (KZIA) posted Other Non-Current Assets of $138207.8 for Q4 2025, down 56.01% on a QoQ basis from $314169.6 in Q2 2025, and down 14.18% year-over-year from $161035.5 in Q4 2024.
Kazia Therapeutics (KZIA) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Kazia Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $138207.8 for Q4 2025.
- Quarterly Other Non-Current Assets fell 14.18% year-over-year to $138207.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138207.8 (down 14.18% YoY) and the FY2025 annual result came in at $314169.6, down 19.36% from the prior year.
- Other Non-Current Assets was $138207.8 for Q4 2025 at Kazia Therapeutics, down from $314169.6 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.3 million in Q2 2021 and bottomed at $138207.8 in Q4 2025.
- A 4-year average of $616051.9 and a median of $423731.2 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 276.04% — and 2024, when it slumped 64.83%.
- Kazia Therapeutics' Other Non-Current Assets stood at $1.1 million in 2021, then sank by 56.48% to $457872.2 in 2023, then tumbled by 64.83% to $161035.5 in 2024, then declined by 14.18% to $138207.8 in 2025.
- Business Quant data shows KZIA's Other Non-Current Assets at $138207.8 in Q4 2025, $314169.6 in Q2 2025, and $161035.5 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 138,207.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138,207.84 |
| Jun 30, 2025 | 314,169.63 |
| Dec 31, 2024 | 161,035.50 |
| Jun 30, 2024 | 389,590.23 |
| Dec 31, 2023 | 457,872.20 |
| Jun 30, 2023 | 1.09 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Jun 30, 2021 | 1.32 Mn |
| Dec 31, 2020 | 738,787.94 |
| Jun 30, 2020 | 352,160.78 |
| Dec 31, 2019 | 123,787.68 |
| Jun 30, 2019 | 258,897.35 |
| Dec 31, 2018 | 103,361.77 |
| Jun 30, 2018 | 581,369.53 |